Your session is about to expire
← Back to Search
Cancer Vaccine for Pancreatic Cancer
Study Summary
This trial tests a new cancer vaccine given with or without a low dose of chemotherapy. The goal is to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the FDA sanction this medication?
"Power's assessment rates the safety of this trial as a 2. While there is some evidence backing its safety, Phase 2 trials have not yet established efficacy."
What are the usual conditions that doctors prescribe this medication for?
"This treatment can help patients with multiple sclerosis, mixed-cell type lymphoma, and leukemia, myelocytic, acute."
How many individuals are being recruited for this clinical trial?
"Yes. The most recent update on clinicaltrials.gov was on March 3rd, 2022 and it indicates that this study is still looking for 72 volunteers at a single site."
Are people still being signed up for this clinical trial?
"Yes, this is an ongoing study that has currently posted on clinicaltrials.gov seeking 72 participants from 1 site. The trial was first published on 4/20/2010 and the most recent update was 3/3/2022."
Share this study with friends
Copy Link
Messenger